NCT04821336View on ClinicalTrials.gov

Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

December 31, 2022

Conditions
Thyroid Cancer
Interventions
OTHER

Metabolites dosage

"On samples investigators will quantify cholesterol metabolite and dendrogenin A (DDA) and 6-oxo-cholestane-3β,5α-diol (ou OCDO) metabolites in malignant tissue sample on one hand, and in sane samples on other hand.~The investigators will compare the rate of deregulation between sane and malignant ones."

Trial Locations (1)

31059

Institut Claudius regaud IUCT Oncopole, Toulouse

Sponsors
All Listed Sponsors
collaborator

Cancer Research Center of Toulouse

UNKNOWN

lead

Institut Claudius Regaud

OTHER

NCT04821336 - Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance | Biotech Hunter | Biotech Hunter